Periodic Reporting for period 1 - SwitchTargeting (Engineering B cells against HIV using Switch targeting)

After having claimed almost 33 million lives so far, there are currently 38M HIV-infected people worldwide and among them 2.5M residing in Europe. Lifelong antiretroviral therapy (ART) is generally well-tolerated and effective. However, due to considerable gaps in...